Compare ClearPoint Neuro Inc (CLPT) vs SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? ClearPoint Neuro Inc trades at $15.7 (market cap $478.63M), while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $57.32. The key difference: SP Funds S&P 500 Sharia Industry Exclusions ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | SPUS | |
|---|---|---|
Market Cap | $478.63M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $29.60 | $59.51 |
52-Week Low | $8.66 | $45.13 |
Enterprise Value | $506.63M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $16.51, down 5.66% on the day, with a bullish technical signal from moving averages but negative profitability. The company reported record Q1 2026 revenue of $36.97M with 25% organic device growth, though it missed EPS estimates with a $0.32 loss. Recent FDA clearance for the Velocity Alpha surgical drill and a partnership with Sungkyunkwan University highlight expansion efforts in neurosurgical navigation and drug delivery.
Outlook remains speculative with 100% analyst buy ratings anticipating gene therapy commercialization upside, but high execution and regulatory risks persist amid consistent losses and negative margins. The stock's valuation at 11.31x sales reflects growth expectations, yet cash burn from operations requires careful monitoring of financing sustainability.
SPUS trades at $57.00, down 1.35% today, with a bullish technical signal from moving averages and neutral oscillators. Recent dividend distributions of $0.03 per share occurred in April, May, and June 2026, reflecting a shareholder return focus. The stock's support and resistance levels are tightly clustered around the current price, indicating potential for near-term consolidation.
The outlook is supported by technical strength but lacks fundamental valuation metrics for deeper analysis. Risks include market volatility and dependence on broader equity trends. Investor sentiment appears neutral, with institutional interest noted from recent filings, though analyst consensus data is unavailable.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About SP Funds S&P 500 Sharia Industry Exclusions ETF
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →
